In the very recent paper by El Bably et al. from 2023, the goal was to distinguish between rheumatoid arthritis (RA), psoriatic arthritis (PsA) and solely psoriasis based on gal-1 assessment [20]. The gene discussed is GAL; the disease is psoriasis.